Social isolation refers to limited social contact and interaction with others, resulting in feelings of loneliness and disconnection. It disproportionately affects the elderly due to factors like loss of friends and family, retirement, reduced mobility, ageism, and limited access to technology. The elderly are at higher risk of social isolation as they may experience a shrinking social circle and face barriers to social participation. Social isolation has significant detrimental effects on their mental and physical well-being, leading to increased rates of depression, anxiety, cognitive decline, and reduced quality of life. Addressing social isolation among the elderly is crucial for promoting their overall health and happiness.
Social prescribing is a healthcare approach that recognises the importance of social factors in overall well-being. It involves connecting individuals with non-medical activities and community resources to improve their health and quality of life. Healthcare professionals, such as doctors or social workers, “prescribe” activities like art classes, gardening, exercise groups, or support groups, which can address underlying social determinants of health and promote holistic well-being. By addressing social isolation, mental health, and lifestyle factors, social prescribing aims to enhance individual health outcomes and reduce the burden on healthcare services.
Social prescribing provides support in various areas of people’s lives, leading to increased confidence, improved navigation of systems, and enhanced friendships and trust in healthcare, while communities should be designed in an age-friendly way to prevent isolation.
In Part 2 of the Models of Care on Social Prescribing, Australian Health Journal spoke to 4 people involved in the Connect Local program under the Connecting Communities to Care 4 year program. The free program for over 65’s promotes wellbeing through social connection and is underway in the Glen Eira community in Melbourne.
- Deidre McGill, Executive General Manager, At Home Support, Bolton Clarke
- Ann Van Leerdam, Connect Local Community Connector, Bolton Clarke
- Dr Rajna Ogrin, Senior Research Fellow, Bolton Clarke Research Institute, Bolton Clarke
- Dr Daniel Fineberg, Deputy Director General Medicine, Alfred Hospital, Victoria
Also to watch
In Part 1 of the Models of Care on Social Prescribing, Australian Health Journal spoke to 4 people advocating for social prescribing in Australia.
Produced with assistance from Australian Primary Health Care Nurses Association (APNA) and Bolton Clarke
-
Orthopaedic surgeon driven to understand & manage infection
In tandem with his clinical practice, Associate Professor Tetsworth is deeply engaged in orthopaedic research, with a keen interest in infection management, infection control, limb salvage, bone defect reconstruction, biomarker development for infection, bone growth hormone delivery, and the use of 3D printed models for reconstructing segmental bone defects.
-
Redefining diversity in clinical trials
Ensuring inclusion, diversity, equity and patient input in the development of novel drugs and medical devices has become well accepted in health care. However appropriate implementation of these elements has been a challenge for many. Only by implementing these conscious inputs can patient outcomes be improved and health disparities in marginalised groups be addressed.
Australian Health Journal spoke to Gillian Mason, Consumer and Community Involvement Lead at Hunter Medical Research Institute in Newcastle, NSW on this topic discussed at the recent ARCS Conference in Sydney.
-
Changes in MBS bulk billing incentives address GP capacity in women’s health
Dr. Sneha Wadhwani, a General Practitioner in Bondi, and Conjoint Lecturer at UNSW School of Medicine, is actively involved in enhancing women’s health services across Australia. As the Co-founder and Clinical Director of Evoca Women’s Health, she highlights the significant improvements in funding for women’s health, particularly with the new MBS bulk billing incentives, in new codes, that commenced on November 1, 2025.
